The over-the-counter softgels are used to relieve pressure, bloating, and fullness by rapidly breaking up gas bubbles in the ...

The phase 3 trial is evaluating the long-term effects of sibeprenlimab-szsi on kidney function in adults with primary immunoglobulin A nephropathy.

Ranluspec is the only interchangeable ranibizumab biosimilar approved in both vial and prefilled syringe presentations.

Top food researchers have teamed up on a special issue of the American Journal of Public Health to push policymakers for stricter action on ultra-processed food ...

At Michigan schools where only 30% to 40% of students are now vaccinated, it is “simply not possible to keep diseases like measles at bay." ...

Children with fall birthdays more likely to be vaccinated, less likely to be diagnosed with influenza than those with summer birthdays.

A phase 2 trial is investigating MTX-001, an injectable regenerative therapy, for patients with noninfected venous leg ulcers.

Zaynich is a combination of cefepime, a cephalosporin antibacterial, and zidebactam, a beta-lactamase inhibitor and non-beta-lactam antibacterial.

"Most adults covered by Medicaid are already working, caregiving or would not be subject to this policy due to illness or disability," said ACP President Dr Jan Carney.

The FDA has granted Priority Review to the BLA for atacicept in the treatment of adults with immunoglobulin A nephropathy (IgAN). Atacicept is a recombinant fusion protein that binds to and inhibits ...

The combination regimen significantly improved progression-free survival and objective response rates in patients who were intolerant to or failed prior imatinib therapy ...

Clinically meaningful improvements seen in overall, progression-free survival for those with RAS G12 mutation, overall population.